151 related articles for article (PubMed ID: 34418461)
1. Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
Xia R; Li H; Shi J; Liu W; Cao M; Sun D; He S; Yu Y; Li N; Lei L; Zhuang G; Chen W
Gastrointest Endosc; 2022 Feb; 95(2):225-235.e20. PubMed ID: 34418461
[TBL] [Abstract][Full Text] [Related]
2. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
[TBL] [Abstract][Full Text] [Related]
3. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.
Hur C; Choi SE; Kong CY; Wang GQ; Xu H; Polydorides AD; Xue LY; Perzan KE; Tramontano AC; Richards-Kortum RR; Anandasabapathy S
World J Gastroenterol; 2015 May; 21(18):5513-23. PubMed ID: 25987774
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.
Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L
Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115
[TBL] [Abstract][Full Text] [Related]
5. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China.
Li H; Ding C; Zeng H; Zheng R; Cao M; Ren J; Shi J; Sun D; He S; Yang Z; Yu Y; Zhang Z; Sun X; Guo G; Song G; Wei W; Chen W; He J
Cancer Commun (Lond); 2021 Aug; 41(8):715-725. PubMed ID: 34146456
[TBL] [Abstract][Full Text] [Related]
6. Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study.
Qin S; Wang X; Li S; Tan C; Zeng X; Luo X; Yi L; Peng L; Wu M; Peng Y; Wang L; Wan X
Pharmacoeconomics; 2022 Jul; 40(7):725-737. PubMed ID: 35701687
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness analysis of esophageal cancer once-in-a-lifetime endoscopic screening in high-risk areas of rural China].
Feng H; Song G; Yang J; Hao C; Wang M; Li B; Zhao D; Liu Z; Wei W; Qiao Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):476-80. PubMed ID: 26463155
[TBL] [Abstract][Full Text] [Related]
8. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis.
Zou Z; Fairley CK; Ong JJ; Hocking J; Canfell K; Ma X; Chow EPF; Xu X; Zhang L; Zhuang G
Lancet Glob Health; 2020 Oct; 8(10):e1335-e1344. PubMed ID: 32971056
[TBL] [Abstract][Full Text] [Related]
9. Risk-based lung cancer screening in heavy smokers: a benefit-harm and cost-effectiveness modeling study.
Liu Y; Xu H; Lv L; Wang X; Kang R; Guo X; Wang H; Zheng L; Liu H; Guo L; Chen Q; Liu S; Qiao Y; Zhang S
BMC Med; 2024 Feb; 22(1):73. PubMed ID: 38369461
[TBL] [Abstract][Full Text] [Related]
10. Polygenic risk-stratified screening for nasopharyngeal carcinoma in high-risk endemic areas of China: a cost-effectiveness study.
Yang DW; Miller JA; Xue WQ; Tang M; Lei L; Zheng Y; Diao H; Wang TM; Liao Y; Wu YX; Zheng XH; Zhou T; Li XZ; Zhang PF; Chen XY; Yu X; Li F; Ji M; Sun Y; He YQ; Jia WH
Front Public Health; 2024; 12():1375533. PubMed ID: 38756891
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.
Nayak S; Roberts MS; Greenspan SL
Ann Intern Med; 2011 Dec; 155(11):751-61. PubMed ID: 22147714
[TBL] [Abstract][Full Text] [Related]
12. A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score.
Zhao Z; Gu S; Yang Y; Wu W; Du L; Wang G; Dong H
BMC Cancer; 2024 Jan; 24(1):73. PubMed ID: 38218803
[TBL] [Abstract][Full Text] [Related]
13. Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Deuffic-Burban S; Huneau A; Verleene A; Brouard C; Pillonel J; Le Strat Y; Cossais S; Roudot-Thoraval F; Canva V; Mathurin P; Dhumeaux D; Yazdanpanah Y
J Hepatol; 2018 Oct; 69(4):785-792. PubMed ID: 30227916
[TBL] [Abstract][Full Text] [Related]
14. [Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences].
Shi JF; Mao AY; Bai YN; Liu GX; Liu CC; Wang H; Cao MM; Feng H; Wang L; Bai FZ; Huang HY; Bai HJ; Zhu J; Yan XX; Zhang J; Ren JS; Li N; Dai M; Chen WQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):306-313. PubMed ID: 32187937
[No Abstract] [Full Text] [Related]
15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Treatment Thresholds for Subsolid Pulmonary Nodules in CT Lung Cancer Screening.
Hammer MM; Eckel AL; Palazzo LL; Kong CY
Radiology; 2021 Sep; 300(3):586-593. PubMed ID: 34128723
[TBL] [Abstract][Full Text] [Related]
17. Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study.
Qin S; Wang X; Li S; Tan C; Zeng X; Wu M; Peng Y; Wang L; Wan X
Front Public Health; 2022; 10():955120. PubMed ID: 36033760
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
19. Decision tree-Markov model of perinatal depression screening: a cost-utility analysis.
Yang Y; Zheng R; Yang L; Huang X; Zhang T
Front Public Health; 2024; 12():1308867. PubMed ID: 38832225
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.
Jaine R; Kvizhinadze G; Nair N; Blakely T
Lung Cancer; 2018 Oct; 124():233-240. PubMed ID: 30268467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
